Gladstone Institutes - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Region:North America

Author(s):

Product Code:GDPH142009D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

November 2018

Total pages

46

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Gladstone Institutes (Gladstone) is a non-profit life science research organization that offers medical research programs. The organization carries out research and development in the areas of cardiovascular disease, virology and immunology, neurological disease, stem cell biology and regenerative medicine, biofulcrum, and others. It also provides training programs for graduate students; and run drug tests on heart cells created from a patient's own skin cells, medical students and postdoctoral fellows. Gladstone offers core facilities services in assay development and drug discovery, neurobehavioral, bioinformatics, flow cytometry, genomics, histology and light microscopy, mass spectometry, stem cell, and transgenic gene targeting. The organization partners with other research institutes. Gladstone is headquartered in San Francisco, California, the US.

Gladstone Institutes-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Gladstone Institutes, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gladstone Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Gladstone Institutes, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Aelan Cell Technologies Enters into Agreement with Gladstone Institutes 10

Gladstone Institutes Enters into Joint Venture with Dolby Family Ventures and Evotec 11

Gladstone Enters into Research Agreement with Takeda Pharma 12

ALS Therapy Enters Into Research Agreement With Gladstone For ALS Treatments 13

Licensing Agreements 14

Fate Therapeutics Enters into License Agreement with Gladstone Institutes 14

Equity Offering 15

Tenaya Therapeutics Spin Off from Gladstone Institutes 15

Gladstone Institutes-Key Competitors 16

Gladstone Institutes-Key Employees 17

Gladstone Institutes-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Joint Venture 18

Recent Developments 19

Strategy And Business Planning 19

Jan 22, 2018: Gladstone Launches Three New Research Centers 19

Government and Public Interest 21

Oct 15, 2018: New immunotherapy targeting blood-clotting protein protects multiple sclerosis and Alzheimer's disease models 21

Oct 10, 2018: USD 3.6 Million to Study Adverse Effects of Genome Editing 23

Sep 12, 2018: Scientists Map Interactions between Head and Neck Cancer and HPV Virus 25

Aug 20, 2018: Two Molecules Offer Great Potential to Combat Cancer and Chronic Infections 27

Aug 16, 2018: New Approach to Fight Tuberculosis, a Leading Cause of Death Worldwide 29

Aug 15, 2018: A New Research Partnership to Find Treatments for Neurological Disorders 31

Apr 09, 2018: Scientists Fix Genetic Risk Factor for Alzheimer's Disease in Human Brain Cells 32

Mar 01, 2018: Gladstone Institutes: Unlocking a Cell's Potential to Regenerate the Heart 34

Mar 01, 2018: Unlocking a cell's potential to regenerate the heart 36

Jan 18, 2018: Researchers Create First Stem Cells Using CRISPR Genome Activation 37

Nov 30, 2017: An Anti-Aging Protein Could Be Targeted to Rejuvenate Immune Cells 38

Nov 02, 2017: Gladstone Institutes: Blood-Clotting Protein Prevents Repair in the Brain 40

May 17, 2017: Cancer-cardiac connection illuminates promising new drug for heart failure 42

May 10, 2017: Study Reveals a New Method to Address a Major Barrier to Eradicating HIV 43

Other Significant Developments 44

Jul 03, 2018: Roddenberry Gift Ushers Gladstone Stem Cell Research into the Future 44

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46


List of Figure

List of Figures

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List of Table

List of Tables

Gladstone Institutes, Pharmaceuticals & Healthcare, Key Facts 2

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gladstone Institutes, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gladstone Institutes, Deals By Therapy Area, 2012 to YTD 2018 8

Gladstone Institutes, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Aelan Cell Technologies Enters into Agreement with Gladstone Institutes 10

Gladstone Institutes Enters into Joint Venture with Dolby Family Ventures and Evotec 11

Gladstone Enters into Research Agreement with Takeda Pharma 12

ALS Therapy Enters Into Research Agreement With Gladstone For ALS Treatments 13

Fate Therapeutics Enters into License Agreement with Gladstone Institutes 14

Tenaya Therapeutics Spin Off from Gladstone Institutes 15

Gladstone Institutes, Key Competitors 16

Gladstone Institutes, Key Employees 17

Gladstone Institutes, Subsidiaries 18

Gladstone Institutes, Joint Venture 18

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022